Search

everythinglearnresearchcommunity

for

Search:↓

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Steroids are the best treatment for Alopecia Areata with few side effects.